Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 4, 2016

View Archived Issues

Avalanche Biotechnologies to acquire Annapurna Therapeutics

Starpharma reports additional preclinical results for targeted dendrimer conjugate

FDA grants fast track designation to NDI-010976 for NASH

Oricula Therapeutics receives NIH grant to support development of ORC-13661

Mersana and Takeda expand partnership to advance development of Fleximer-based ADC therapies

Bayer Schering Pharma patents GLUT-1 inhibitors

Roche discloses BACE1 inhibitors

Merck & Co. develops ROMK channel blockers

Shionogi reports ITK inhibitors

FDA grants fast track designation for emricasan as treatment of patients with NASH cirrhosis

Shareholders approve Pozen merger with Tribute Pharmaceuticals

New AAV variant transfers genes throughout the CNS in vivo

Modulate Therapeutics established to develop immunomodulator combination IMM-01

Greenville Health System and Selah Genomics launch test for risk of sudden cardiac death

Heat Biologics provides update on its HS-410 phase II bladder cancer trial

Takeda Pharmaceutical to create wholly owned consumer healthcare subsidiary

Human fallopian tube organoid model faithfully recapitulates the mucosal fold architecture

Kyorin returns Japanese rights to aclidinium/formoterol to AstraZeneca

Defibrotide deemed effective against veno-oclussive disease in phase III trial

Pfizer profiles pipeline progress of fourth quarter 2015

Exosome-encapsulated paclitaxel shows promise to treat drug-resistant cancers

FDA grants fast track designation to TapImmune's TPIV-200 for ovarian cancer

FDA advisory committee votes on Brintellix to treat cognitive dysfunction in MDD

Mitsubishi Tanabe Pharma updates progress of third quarter of fiscal 2015

Morphotek provides folate receptor alpha diagnostic assays for Mayo Clinic study

GeoVax Labs announces its plans to develop Zika virus vaccine

Fast Forward Pharmaceuticals begins phase II studies of FFP-104

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...